Nexstim Oyj (NXTMH) - Total Liabilities

Latest as of June 2025: €9.17 Million EUR ≈ $10.72 Million USD

Based on the latest financial reports, Nexstim Oyj (NXTMH) has total liabilities worth €9.17 Million EUR (≈ $10.72 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See NXTMH defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Nexstim Oyj - Total Liabilities Trend (2012–2024)

This chart illustrates how Nexstim Oyj's total liabilities have evolved over time, based on quarterly financial data. Check Nexstim Oyj liquidity resilience to evaluate the company's liquid asset resilience ratio.

Nexstim Oyj Competitors by Total Liabilities

The table below lists competitors of Nexstim Oyj ranked by their total liabilities.

Company Country Total Liabilities
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
USA $132.00K
DENARIUS METALS CORP.
F:T7C0
Germany €72.65 Million
Semyung Electric Machinery Co.Ltd
KQ:017510
Korea ₩20.49 Billion
Midnight Sun Mining Corp
V:MMA
Canada CA$678.98K
Wellell Inc
TW:4106
Taiwan NT$729.71 Million
Axon Partners Group S.A.
MC:APG
Spain €6.70 Million
NTT System SA
WAR:NTT
Poland zł256.18 Million
Vocento
MC:VOC
Spain €173.46 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Nexstim Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NXTMH current and non-current assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.74 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nexstim Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nexstim Oyj (2012–2024)

The table below shows the annual total liabilities of Nexstim Oyj from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 €10.50 Million
≈ $12.28 Million
+49.04%
2023-12-31 €7.05 Million
≈ $8.24 Million
+14.66%
2022-12-31 €6.15 Million
≈ $7.19 Million
-10.11%
2021-12-31 €6.84 Million
≈ $7.99 Million
-11.21%
2020-12-31 €7.70 Million
≈ $9.00 Million
-8.27%
2019-12-31 €8.39 Million
≈ $9.81 Million
-15.68%
2018-12-31 €9.96 Million
≈ $11.64 Million
+80.27%
2017-12-31 €5.52 Million
≈ $6.46 Million
-7.00%
2016-12-31 €5.94 Million
≈ $6.94 Million
+4.90%
2015-12-31 €5.66 Million
≈ $6.62 Million
+4.76%
2014-12-31 €5.40 Million
≈ $6.32 Million
-0.47%
2013-12-31 €5.43 Million
≈ $6.35 Million
+48.42%
2012-12-31 €3.66 Million
≈ $4.28 Million
--

About Nexstim Oyj

HE:NXTMH Finland Medical Devices
Market Cap
$77.59 Million
€66.36 Million EUR
Market Cap Rank
#20248 Global
#94 in Finland
Share Price
€9.20
Change (1 day)
+2.11%
52-Week Range
€8.14 - €16.40
All Time High
€705.72
About

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more